Recent updates to the label include stronger wording for different forms of pancreatitis, acute kidney injury due to volume depletion (loss of fluids), and diabetic retinopathy complications in patients with a history of diabetic retinopathy
Read the MHRA Mounjaro Patient Information Leaflet and the EMA Summary of Product Characteristics for Tirzepatide for full side effects and warnings
doi: 10.1152/ajprenal.2000.279.5.F793
Yes, you can change your weekly injection day provided there are at least 3 days (72 hours) between doses
Clinical Trial Results and Effectiveness Clinical trial data published in The New England Journal of Medicine, such as the SURMOUNT-5 trial, has demonstrated Zepbounds superior efficacy in weight loss compared to Wegovy, with participants on Zepbound achieving a mean weight loss of 20.2% versus 13.7% with Wegovy over a 72-week period
Drawing on current evidence and clinical experience, a synergistic approach that combines GLP-1 RAs with targeted MNT appears to be the most effective strategy to support sustainable weight loss while preserving MM
